The effectiveness of the Guy’s Rapid Diagnostic Clinic (RDC) in detecting cancer and serious conditions in vague symptom patients
Open Access
- 5 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 124 (6), 1079-1087
- https://doi.org/10.1038/s41416-020-01207-7
Abstract
Background Rapid Diagnostic Clinics (RDC) are being expanded nationally by NHS England. Guy’s RDC established a pathway for GPs and internal referrals for patients with symptoms concerning for malignancy not suitable for a site-specific 2WW referral. However, little data assessing the effectiveness of RDC models are available in an English population. Methods We evaluated all patients referred to Guy’s RDC between December 2016 and June 2019 (n = 1341) to assess the rate of cancer diagnoses, frequency of benign conditions and effectiveness of the service. Results There were 96 new cancer diagnoses (7.2%): lung (16%), haematological (13%) and colorectal (12%)—with stage IV being most frequent (40%). Median time to definitive cancer diagnosis was 28 days (IQR 15–47) and treatment 56 days (IQR 32–84). In all, 75% were suitable for treatment: surgery (26%), systemic (24%) and radiotherapy (14%). Over 180 serious non-neoplastic conditions were diagnosed (35.8%) of patients with no significant findings in two-third of patients (57.0%). Conclusions RDCs provide GPs with a streamlined pathway for patients with complex non-site-specific symptoms that can be challenging for primary care. The 7% rate of cancer diagnosis exceeds many 2WW pathways and a third of patients presented with significant non-cancer diagnoses, which justifies the need for rapid diagnostics. Rapid Diagnostic Centres (RDCs) are being rolled out nationally by NHS England and NHS Improvement as part of the NHS long-term plan. The aim is for a primary care referral pathway that streamlines diagnostics, patient journey, clinical outcomes and patient experience. This pilot study of 1341 patients provides an in-depth analysis of the largest single RDC in England. Cancer was diagnosed in 7% of patients and serious non-cancer conditions in 36%—justifying the RDC approach in vague symptom patients.Keywords
This publication has 30 references indexed in Scilit:
- COVID-19: impact on cancer workforce and delivery of carePublished by Elsevier BV ,2020
- Patient–physician relationship and use of gut feeling in cancer diagnosis in primary care: a cross-sectional survey of patients and their general practitionersBMJ Open, 2019
- The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancerBMJ Open, 2018
- Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sitesBritish Journal of Cancer, 2017
- The “two-week wait” referral pathway is not associated with improved survival for patients with colorectal cancerInternational Journal of Surgery, 2017
- Symptoms of adult chronic and acute leukaemia before diagnosis: large primary care case-control studies using electronic recordsBritish Journal of General Practice, 2016
- Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic reviewBritish Journal of Cancer, 2015
- A differentiated approach to referrals from general practice to support early cancer diagnosis – the Danish three-legged strategyBritish Journal of Cancer, 2015
- Variation in use of the 2-week referral pathway for suspected cancer: A cross-sectional analysisBritish Journal of General Practice, 2012
- Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: a nationwide Danish studyQuality of Life Research, 2011